Even as more damning data are coming to light, Pfizer and Moderna are both seeking emergency use authorization (EUA) for their bivalent COVID boosters for children. Moderna is seeking authorization for children ages 6 through 17, while Pfizer’s shot is for children aged 5 through 11.1 According to Reuters,2 “the U.S. Centers for Disease Control and Prevention … expects COVID-19 vaccine boosters targeting circulating variants of the virus to be available for children aged 5-11 years by mid-October.” Moderna’s new bivalent COVID booster, mRNA-1273.222, sold under the brand name “Spikevax bivalent Original/Omicron,” was authorized for adults over the age of 18 … Continue reading Moderna and Pfizer Seek Booster Authorization for Children